Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings
Shek Man Chim, Kristen Howell, John Dronzek, Weizhen Wu, Cristopher V. Van Hout, Manuel A. R. Ferreira, Bin Ye, Alexander H. Li, Susannah D. Brydges, Arunachalam Vinayagam, Anthony Marcketta, Adam E. Locke, Jonas Bovijn, Niek Verweij, Tanima De, , Harikiran Nistala
The paper identifies SLC39A5 as a gene whose loss-of-function variants are associated with reduced type II diabetes risk and improved liver function in metabolic disorders.
eLife · Dec 13, 2024Peer-reviewedGenetic & Genomic Medicine